Patent details

EP3254675 Title: DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME

Basic Information

Publication number:
EP3254675
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP171811748
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DELAYED RELEASE, ORAL DOSAGE COMPOSITIONS THAT CONTAIN AMORPHOUS CDDO-ME
French Title of Invention:
COMPOSITIONS PHARMACEUTIQUES ORALES À LIBÉRATION RETARDÉE CONTENANT DU CDDO-ME AMORPHE
German Title of Invention:
ORALE DARREICHUNGSZUSAMMENSETZUNGEN MIT VERZÖGERTER FREISETZUNG MIT AMORPHEM CDDO-ME
SPC Number:

Dates

Filing date:
12/02/2010
Grant date:
15/05/2019
EP Publication Date:
13/12/2017
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
15/05/2019
EP B1 Publication Date:
15/05/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
12/02/2030
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
08/12/2022
 
 

Name:
REATA PHARMACEUTICALS HOLDINGS, LLC
Address:
5320 Legacy Drive, Plano, 75024, Texas, Texas, United States (US)

History of Owners

From:
08/05/2019
To:
08/12/2022

Name:
Reata Pharmaceuticals, Inc.
Address:
2801 Gateway Drive, Suite 150, Irving, TX 75063, United States (US)

Agent

Name:
Dennemeyer & Associates S.A.
From:
25/06/2019
Address:
55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
To:

Inventor

1

Name:
MEYER, Colin J.
Address:
United States (US)

2

Name:
ZHANG, Jiang
Address:
United States (US)

Priority

Priority Number:
152608 P
Priority Date:
13/02/2009
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/16; A61K 9/48; A61K 31/70;

Publication

Bulletin

Bulletin Heading:
CO
Bulletin edition number:
2023/01
Publication date:
03/01/2023
Description:
Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

Issue number:
201920
Publication date:
15/05/2019
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Change of ownership
Deed Number:
RC20220000479A
Date Registered:
08/12/2022
Licence Effective Date:
Licence Expiration Date:
Scope of Licence:
Deed Filer:
OFFICE FREYLINGER S.A.
Journal Edition Number:
Text:
Country Code:
Updated Licence Number:
Terminated Licence Number:

Added Owner(s)

Name:
REATA PHARMACEUTICALS HOLDINGS, LLC
Address:
5320 Legacy Drive, Plano, 75024, Texas, United States (US)

Removed Pledgee

Name:
Address:

Annual Fees

Annual Fee Due Date:
02/03/2026
Annual Fee Number:
17
Annual Fee Amount:
246 Euro
Expected Payer:
Last Annual Fee Payment Date:
21/01/2025
Last Annual Fee Paid Number:
16
Last Annual Fee Paid Amount:
230 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages
08/12/2022 Request For Change 5
08/12/2022 Outgoing Correspondence 1
01/07/2019 Outgoing Correspondence 1
25/06/2019 Power Of Attorney 2